Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Urology|March 29, 2000
One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General PracticeB Lukacs, J C Grange, D Comet
L'Encephale|December 16, 1998
[alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo]E G Hantouche, J D Guelfi, D Comet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 1, 1994
[Development and validation of a quality of life scale associated with health status, specific for benign hypertrophy of the prostate and including a sexuality evaluation scale]B Lukacs, C McCarthy, A Leplege, et al.
European Urology|March 8, 2000
History of 7,093 patients with lower urinary tract symptoms related to benign prostatic hyperplasia treated with alfuzosin in general practice up to 3 yearsB Lukacs, J C Grange, D Comet, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in General PracticeB Lukacs, J C Grange, D Comet, et al.
European Urology|April 29, 1998
Clinical uroselectivity: a 3-year follow-up in general practice. BPH Group in General PracticeB Lukacs, J C Grange, C McCarthy, et al.
British Journal of Urology|December 11, 1997
Construction and validation of a short-form benign prostatic hypertrophy health-related quality-of-life questionnaire. BPH Group in General PracticeB Lukacs, D Comet, J C Grange, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 17, 1999
[Prospective follow-up of 3,228 patients suffering from clinical benign prostatic hyperplasia (BPH) treated for 3 years wi alfuzosin in general practice. BPH Group in General Practice]B Lukacs, J C Grange, D Comet, et al.
L'Encephale|April 2, 2013
[Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists]D Misdrahi, A Delgado, S Bouju, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 28, 2009
[Impact of nocturia on sleep efficiency in patients with benign prostatic hypertrophy]E Chartier-Kastler, D Leger, V Montauban, et al.
Pageof 2